Research shows that patients with moderate to severe ulcerative colitis have significantly lower vitamin D levels and higher inflammation markers compared to those with mild disease. A 2026 cross-sectional study of 50 Egyptian patients found that vitamin D had a strong negative correlation with TNF-alpha (r = -0.669), a key inflammation protein, suggesting that vitamin D deficiency is closely linked to increased intestinal inflammation in ulcerative colitis.
Researchers at Egyptian Military Hospitals studied 50 patients with ulcerative colitis, a chronic gut inflammation disease, to understand the connection between vitamin D levels and disease severity. They found that patients with more severe symptoms had significantly lower vitamin D levels and higher levels of TNF-alpha, a protein that causes inflammation. According to Gram Research analysis, vitamin D appears to play an important role in controlling the inflammatory response in ulcerative colitis. The study suggests that checking vitamin D levels might help doctors better understand and potentially manage this painful digestive condition.
Key Statistics
A 2026 cross-sectional study of 50 ulcerative colitis patients at Egyptian Military Hospitals found that vitamin D showed a strong negative correlation with TNF-alpha (r = -0.669, p less than 0.001), indicating that lower vitamin D levels were closely associated with higher inflammation.
According to research reviewed by Gram, patients with moderate to severe ulcerative colitis had significantly lower vitamin D concentrations compared to those with mild disease, with vitamin D showing a moderate negative correlation with disease severity (r = -0.466, p-value = 0.001).
A 2026 study of 50 newly diagnosed ulcerative colitis patients found that fecal calprotectin, a marker of gut inflammation, had a strong positive correlation with disease severity (r = 0.704, p less than 0.001), making it a highly reliable indicator of colon inflammation.
Research from Egyptian Military Hospitals showed that TNF-alpha, a pro-inflammatory protein, had a moderate positive correlation with ulcerative colitis severity (r = 0.472, p-value = 0.001), confirming that patients with worse symptoms experienced higher systemic inflammation.
The Quick Take
- What they studied: Whether vitamin D levels are connected to how severe ulcerative colitis is and how much inflammation a person has in their body
- Who participated: 50 adults aged 15 to 70 years old with newly diagnosed ulcerative colitis from Egyptian Military Hospitals. The group included 26 people with mild disease and 24 with moderate to severe disease
- Key finding: Patients with worse ulcerative colitis had much lower vitamin D levels and higher inflammation markers. Vitamin D showed a strong negative correlation with TNF-alpha (r = -0.669), meaning lower vitamin D was linked to more inflammation
- What it means for you: If you have ulcerative colitis, your doctor might want to check your vitamin D levels as part of managing your condition. Low vitamin D could be a sign of more severe inflammation, though this study doesn’t prove vitamin D supplements will help
The Research Details
This was a cross-sectional observational study, which means researchers looked at a group of people at one point in time rather than following them over months or years. The study took place over six months at military hospitals in Cairo, Egypt, from July through December 2025. Researchers recruited 50 adults with newly diagnosed ulcerative colitis and divided them into two groups based on disease severity: 26 with mild symptoms and 24 with moderate to severe symptoms.
The researchers collected information about each patient’s age, background, and medical history. They performed colonoscopies (a procedure to look inside the colon) to measure disease activity using a scoring system called UCDAI. They also took blood samples to measure vitamin D levels and TNF-alpha, a protein that causes inflammation. Additionally, they measured fecal calprotectin, a marker of gut inflammation found in stool samples, and performed standard blood tests including CBC, ESR, and CRP.
Vitamin D was measured using a method called CLIA (chemiluminescence immunoassay), and TNF-alpha was measured using ELISA (enzyme-linked immunosorbent assay), both reliable laboratory techniques. All measurements were performed at central military laboratories and blood banks to ensure consistency.
This research approach is important because it provides a snapshot of the relationship between vitamin D and ulcerative colitis severity in a real-world patient population. By measuring multiple inflammation markers at the same time, researchers could see how these different measurements relate to each other. This type of study is useful for identifying patterns and generating ideas for future research, even though it cannot prove that low vitamin D causes worse ulcerative colitis.
This study has some strengths and limitations to consider. The researchers used standardized, validated measurement techniques and included multiple markers of inflammation, which strengthens the findings. However, the sample size of 50 patients is relatively small, and the study was conducted only at military hospitals in Egypt, so results may not apply to all populations. The cross-sectional design means we see only a single moment in time for each patient, not how things change over time. Additionally, the study did not measure other factors that might affect vitamin D levels or inflammation, such as diet, sun exposure, or medications patients were taking.
What the Results Show
The study found strong connections between vitamin D levels, inflammation, and ulcerative colitis severity. Vitamin D showed a moderate negative correlation with disease severity (r = -0.466, p-value = 0.001), meaning patients with more severe disease tended to have lower vitamin D. More importantly, vitamin D showed a strong negative correlation with TNF-alpha (r = -0.669, p-value less than 0.001), indicating that lower vitamin D was closely linked to higher inflammation levels.
TNF-alpha, the inflammation protein, showed a moderate positive correlation with disease severity (r = 0.472, p-value = 0.001), confirming that patients with worse symptoms had more inflammation. Fecal calprotectin, a marker of gut inflammation, had an even stronger correlation with disease severity (r = 0.704, p-value less than 0.001), making it a very reliable indicator of how inflamed the colon was.
Patients with moderate to severe ulcerative colitis had significantly lower vitamin D levels compared to those with mild disease. These same patients also had markedly elevated TNF-alpha and fecal calprotectin levels, showing that their bodies were producing much more inflammation. This pattern suggests that vitamin D deficiency and high inflammation go hand in hand in ulcerative colitis.
Fecal calprotectin also showed a weak positive correlation with TNF-alpha (r = 0.388, p-value = 0.005), meaning that patients with more inflammation in their stool also tended to have higher blood inflammation markers. This suggests that different ways of measuring inflammation in ulcerative colitis are related to each other. The study also confirmed that standard blood tests like ESR and CRP were elevated in patients with more severe disease, supporting the idea that ulcerative colitis causes systemic (whole-body) inflammation, not just local gut inflammation.
Previous research has shown that vitamin D deficiency is common in autoimmune diseases, including ulcerative colitis. This study adds to that evidence by showing a strong relationship between vitamin D levels and TNF-alpha, a key inflammation protein. The findings align with earlier studies suggesting that vitamin D plays a role in controlling immune responses. However, most previous research has been conducted in European or North American populations, so this Egyptian study helps confirm these patterns in a different geographic region and population.
Several important limitations should be considered. First, this was a small study with only 50 patients, so results may not apply to larger populations. Second, the study looked at patients at only one point in time, so we cannot determine whether low vitamin D causes worse ulcerative colitis or whether severe ulcerative colitis causes low vitamin D. Third, the study did not measure other factors that affect vitamin D levels, such as sun exposure, diet, skin tone, or use of supplements. Fourth, all participants were from military hospitals in Cairo, Egypt, which may not represent all people with ulcerative colitis worldwide. Finally, the study did not examine whether vitamin D supplementation would improve symptoms or reduce inflammation.
The Bottom Line
Based on this research, doctors caring for ulcerative colitis patients may want to check vitamin D levels as part of routine assessment (moderate confidence). If vitamin D deficiency is found, supplementation might be considered, though this study does not prove that supplements will reduce inflammation or improve symptoms (low to moderate confidence). Patients should not start or stop any treatments based on this single study without consulting their healthcare provider.
This research is most relevant for people with ulcerative colitis and their doctors. It may be particularly important for patients with moderate to severe disease who are looking for additional ways to manage their condition. People living in areas with limited sun exposure or those with dietary restrictions that limit vitamin D intake should be especially interested. However, this study does not apply to people without ulcerative colitis or other inflammatory bowel conditions.
If vitamin D supplementation were to help, benefits would likely take weeks to months to appear, as vitamin D works by gradually modulating the immune system. This is not a quick fix. Patients should expect to work with their doctors on a long-term management plan that may include multiple approaches to controlling inflammation.
Frequently Asked Questions
Is vitamin D deficiency a cause of ulcerative colitis?
This study shows a strong link between low vitamin D and worse ulcerative colitis inflammation, but it does not prove that vitamin D deficiency causes the disease. The relationship could work both ways: low vitamin D might worsen inflammation, or severe inflammation might lower vitamin D levels. More research is needed to determine causation.
Should I take vitamin D supplements if I have ulcerative colitis?
This study does not test whether vitamin D supplements help ulcerative colitis. If your doctor finds you have low vitamin D through blood tests, they may recommend supplementation, but this decision should be made with your healthcare provider based on your individual situation and other research on treatment effectiveness.
What is TNF-alpha and why does it matter in ulcerative colitis?
TNF-alpha is a protein your immune system produces that causes inflammation. In ulcerative colitis, the body makes too much TNF-alpha, leading to excessive gut inflammation and symptoms like diarrhea and abdominal pain. This study found that patients with lower vitamin D had higher TNF-alpha levels.
Can this study’s findings apply to people outside of Egypt?
This study was conducted only at military hospitals in Cairo, Egypt, so results may not apply to all populations worldwide. Genetic differences, sun exposure, diet, and other environmental factors vary by region and could affect vitamin D levels and ulcerative colitis severity differently in other areas.
What is fecal calprotectin and how is it used in ulcerative colitis?
Fecal calprotectin is a protein found in stool that indicates gut inflammation. This study found it had a very strong correlation with ulcerative colitis severity, making it a useful marker for doctors to assess how inflamed your colon is without needing a colonoscopy every time.
Want to Apply This Research?
- Track your vitamin D levels quarterly (every three months) through blood tests ordered by your doctor, and record your ulcerative colitis symptom severity using a simple daily scale from 1 to 10 to see if patterns emerge over time
- If your doctor confirms low vitamin D, use the app to set a reminder to take vitamin D supplements at the same time each day and log when you take them to ensure consistency and adherence
- Create a dashboard that displays your vitamin D levels over time alongside your symptom severity scores and inflammation markers (like fecal calprotectin when available) to help you and your doctor identify trends and adjust treatment as needed
This research describes associations between vitamin D levels and ulcerative colitis severity but does not prove that vitamin D supplements will treat or prevent the disease. Ulcerative colitis is a serious medical condition requiring professional diagnosis and treatment. Do not start, stop, or change any medications or supplements without consulting your gastroenterologist or primary care physician. This article is for educational purposes only and should not replace medical advice from a qualified healthcare provider. If you have ulcerative colitis symptoms, seek evaluation from a medical professional.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.